C4 Therapeutics, Inc. (CCCC)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
Sep 01, 16:00
3.865
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics Cash and Short Term Investments (Quarterly) : 253.66M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 253.66M |
| March 31, 2026 | 235.67M |
| December 31, 2025 | 248.54M |
| September 30, 2025 | 191.88M |
| June 30, 2025 | 214.55M |
| March 31, 2025 | 215.09M |
| December 31, 2024 | 244.90M |
| September 30, 2024 | 255.64M |
| June 30, 2024 | 264.10M |
| March 31, 2024 | 258.19M |
| December 31, 2023 | 253.68M |
| September 30, 2023 | 216.57M |
| June 30, 2023 | 267.28M |
| March 31, 2023 | 270.32M |
| Date | Value |
|---|---|
| December 31, 2022 | 276.15M |
| September 30, 2022 | 313.65M |
| June 30, 2022 | 307.78M |
| March 31, 2022 | 291.17M |
| December 31, 2021 | 309.28M |
| September 30, 2021 | 402.07M |
| June 30, 2021 | 465.91M |
| March 31, 2021 | 313.48M |
| December 31, 2020 | 371.69M |
| September 30, 2020 | 199.41M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 90.55M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.153B |
| Rallybio Corp. | 92.85M |
| Q32 Bio, Inc. | 106.27M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |